Owing to its role as a deubiquinase, CYLD has been associated with multiple kinds of hematological malignancies, including multiple myeloma, T-cell acute lymphoblastic leukemia (T-ALL), and CLL [31-34]. The gene discussed is CYLD; the disease is plasma cell myeloma.